Biotech and Pharmaceuticals
Teva to pay $225 million in fines and divest generic drug to resolve price-fixing charges
Boxes of tablets, produced by Teva Pharmaceutical Industries. Chris Ratcliffe | Bloomberg | Getty Images Drugmaker Teva Pharmaceuticals agreed to pay $225 million in criminal fines over five years and divest its version of a generic cholesterol drug to resolve charges related to price-fixing on that medication and other widely used treatments, the Department of […]
Read More
Covid vaccine stocks jump as new variants emerge ahead of fall shot rollout
Nikos Pekiaridis | Lightrocket | Getty Images Covid vaccine makers’ shares rose Monday as new variants of the virus emerge in the U.S. ahead of the rollout of updated shots this fall. Shares of Novavax jumped more than 13%. Moderna‘s stock rose more than 9%. Shares of BioNTech, which jointly develops Covid vaccines with Pfizer, […]
Read More
Weight loss drugs boost sales at retail pharmacies, but they may not help profits much
A pharmacist displays boxes of Ozempic, a semaglutide injection drug used for treating type 2 diabetes made by Novo Nordisk, at Rock Canyon Pharmacy in Provo, Utah, U.S. March 29, 2023. George Frey | Reuters Drugmakers aren’t the only ones feeling the impact of the weight loss industry gold rush. Retailers with pharmacy businesses, such […]
Read More
This biotech name is one of Jim Cramer’s favorite stocks and he thinks it can go even higher
Regeneron Pharmaceuticals (REGN) rose Monday after the Food and Drug Administration approved a higher-dose formulation of Eylea, the company’s macular degeneration treatment. If you like this story, sign up for Jim Cramer’s Top 10 Morning Thoughts on the Market email newsletter for free. CNBC’s Jim Cramer said on “Squawk on the Street” that Regeneron is […]
Read More
New Covid vaccines from Pfizer, Moderna and Novavax will likely protect against Eris variant
A pharmacist prepares to administer Covid-19 vaccine booster shots during an event hosted by the Chicago Department of Public Health at the Southwest Senior Center in Chicago, Illinois, Sept. 9, 2022. Scott Olson | Getty Images New Covid vaccines from Pfizer, Moderna and Novavax will likely provide protection against the new “Eris” variant, now the […]
Read More
Novartis programs Sandoz spin-off around Oct. 4, proposes share
Novartis engineers in packaging facility. Resource: Novartis Novartis on Friday proposed to present shareholders a person Sandoz share for each five Novartis shares as it claimed it planned to spin off the generic medications division on or all around Oct. 4. The Swiss drugmaker invited shareholders to an incredible basic meeting on Sept. 15 just […]
Read More
Moderna says new Covid vaccine was effective against Eris variant in early trial
Nikos Pekiaridis | Lightrocket | Getty Images Moderna’s new Covid vaccine generated a robust immune response against the now-dominant “Eris” variant and another rapidly spreading strain of the virus in an early clinical trial, the biotech company said Thursday. The updated shot is designed to target omicron subvariant XBB.1.5, but the results suggest that the […]
Read More
Weight loss drugs are priced substantially higher in the U.S. than in other countries, analysis says
In this photo illustration, a box of the diabetes drug Ozempic rests on a pharmacy counter on April 17, 2023 in Los Angeles, California. Mario Tama | Getty Images Blockbuster weight loss drugs are priced significantly higher in the U.S. than in other large, high-income countries, according to a new analysis released Thursday. The report […]
Read More
CVS stock plunges after Blue Shield of California drops retailer’s pharmacy services to save on drug costs
A CVS location in New York, US, on Thursday, Feb. 9, 2023. Stephanie Keith | Bloomberg | Getty Images Shares of CVS Health plunged 9% on Thursday after Blue Shield of California said it will drop the company’s pharmacy benefit management services and instead partner with Mark Cuban’s Cost Plus Drugs company and Amazon Pharmacy […]
Read More
Wegovy could prevent up to 1.5 million heart attacks, strokes over 10 years, study says
A selection of injector pens for the Wegovy weight loss drug are shown in this photo illustration in Chicago, Illinois, March 31, 2023. Jim Vondruska | Reuters Novo Nordisk’s blockbuster weight loss injection Wegovy could prevent up to 1.5 million heart attacks, strokes and other cardiovascular events in the U.S. over 10 years, according to […]
Read More